QBT.L

Quantum Blockchain Technologies Plc
Quantum Blockchain Technologies Plc - Related Party Transaction
2nd August 2024, 06:09
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
1 August 2024

Quantum Blockchain Technologies Plc

( "QBT" or "the Company")

Related Party Transaction

QBT announces that, on 7 April 2023, the Company entered into a consultancy
agreement (the "Agreement") with Infusion (2009) Ltd ("Infusion"), a company
controlled by QBT's executive chairman and chief executive officer, Francesco
Gardin ("FG"), and of which FG is a director. The Agreement commenced with
effect from 1 January 2022.

Under theAgreement, Infusion provides QBT the services of FG as chief research
officer responsible for coordinating and leading QBT's research and development
activities. The Agreement may be terminated by either party providing six
months' notice and, in certain circumstances, QBT may terminate the Agreement
without notice.

The fee payable by QBT to Infusion under the Agreement is £12,500 per month plus
an additional amount, awarded at the discretion of the board of QBT, to reflect
exceptional performance. In the years to 31 December 2022 and 2023, amounts of
€200,000 and €288,000 respectively were paid by QBT to Infusion for the services
of FG provided under the Agreement and have been disclosed in the Company's
annual report and accounts for each of those years.

The entering into the Agreement by QBT is a related party transaction under Rule
13 of the AIM Rules for Companies. With the exception of Francesco Gardin, who
is involved in the transaction as a related party, the directors of the Company
consider, having consulted with the Company's nominated adviser, that the terms
of the transaction are fair and reasonable insofar as its shareholders are
confirmed.

For further information please contact:

Quantum Blockchain Technologies Plc
Francesco Gardin, CEO and Executive Chairman+39 335 296573

SP Angel Corporate Finance (Nominated Adviser & Broker)
Jeff Keating+44 (0)20 3470 0470

Leander (Financial PR)
Christian Taylor-Wilkinson+44 (0) 7795 168 157

About Quantum Blockchain Technologies Plc

QBT (AIM: QBT) is an AIM listed investment company with a strategic focus on
technology related investments, including a special regard towards Quantum
Computing, Blockchain, Cryptocurrencies and AI sectors. The Company has an
aggressive R&D and investment programme in the dynamic world of Blockchain
Technology, which includes cryptocurrency mining and other advanced blockchain
applications.


This information was brought to you by Cision http://news.cision.com
https://news.cision.com/quantum-blockchain-technologies-plc/r/related-party-transaction,c4020734
TwitterFacebookLinkedIn